The bench-to-bedside process begins with basic research conducted in laboratories, where scientists investigate the fundamental mechanisms of cancer. These preclinical studies involve experiments using cell cultures and animal models to understand how cancer develops and progresses. Once promising targets or compounds are identified, the research moves to the translational phase, where these findings are tested in clinical trials to evaluate their safety and efficacy in humans.
